R.-D. Hesch

2.5k total citations · 1 hit paper
24 papers, 2.0k citations indexed

About

R.-D. Hesch is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, R.-D. Hesch has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nephrology. Recurrent topics in R.-D. Hesch's work include Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). R.-D. Hesch is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). R.-D. Hesch collaborates with scholars based in Germany, United States and Czechia. R.-D. Hesch's co-authors include Rolf Knippers, Hannes Hentze, Susanne Englisch, Frank O. Fackelmayer, R. Hehrmann, Harald Jüppner, H. Mohr, Michael J. Atkinson, Gino V. Segre and A.D. Perris and has published in prestigious journals such as FEBS Letters, Journal of Bone and Mineral Research and Journal of Endocrinology.

In The Last Decade

R.-D. Hesch

19 papers receiving 1.9k citations

Hit Papers

DNA fragments in the blood plasma of cancer patients: qua... 2001 2026 2009 2017 2001 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.-D. Hesch Germany 8 1.3k 893 661 507 403 24 2.0k
James L. Bennington United States 25 519 0.4× 910 1.0× 595 0.9× 637 1.3× 310 0.8× 49 2.2k
Phyllis C. Huettner United States 28 799 0.6× 883 1.0× 453 0.7× 357 0.7× 283 0.7× 61 2.5k
Nejat Dalay Türkiye 31 1.6k 1.3× 2.2k 2.4× 790 1.2× 283 0.6× 408 1.0× 116 3.1k
S Hellman United States 13 445 0.3× 453 0.5× 806 1.2× 411 0.8× 359 0.9× 23 1.9k
Charlotte H. Ahern United States 22 338 0.3× 798 0.9× 756 1.1× 541 1.1× 279 0.7× 42 2.0k
Teruhiko Yoshida Japan 24 464 0.4× 1.1k 1.2× 1.1k 1.6× 974 1.9× 191 0.5× 54 2.2k
Takako Kawasaki United States 27 988 0.8× 1.9k 2.1× 1.6k 2.4× 392 0.8× 1.4k 3.5× 29 3.3k
Takashi Sakatani Japan 20 445 0.3× 1.0k 1.1× 707 1.1× 297 0.6× 268 0.7× 72 1.9k
Gro Wiedswang Norway 20 763 0.6× 374 0.4× 1.1k 1.6× 338 0.7× 134 0.3× 38 1.7k
W. J. Mooi Netherlands 26 353 0.3× 1.1k 1.2× 1.2k 1.8× 840 1.7× 283 0.7× 60 2.7k

Countries citing papers authored by R.-D. Hesch

Since Specialization
Citations

This map shows the geographic impact of R.-D. Hesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.-D. Hesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.-D. Hesch more than expected).

Fields of papers citing papers by R.-D. Hesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.-D. Hesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.-D. Hesch. The network helps show where R.-D. Hesch may publish in the future.

Co-authorship network of co-authors of R.-D. Hesch

This figure shows the co-authorship network connecting the top 25 collaborators of R.-D. Hesch. A scholar is included among the top collaborators of R.-D. Hesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.-D. Hesch. R.-D. Hesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hesch, R.-D., et al.. (2015). Endocrinological Aspects of PTH Metabolism in the Kidney1. Contributions to nephrology. 13. 104–114. 1 indexed citations
2.
Brabant, G., et al.. (2008). Hyperprolactinämie und Prolactinome: Ergebnisse operativer und medikamentöser Therapie. DMW - Deutsche Medizinische Wochenschrift. 110(41). 1564–1567.
3.
Hesch, R.-D., et al.. (2008). Medikamentöse Therapie von Hypophysentumoren. DMW - Deutsche Medizinische Wochenschrift. 107(23). 883–886.
5.
König, Stéphane, et al.. (1992). Increased bone mass with the combination therapy of hPTH(1–38) and rhGH in osteoporotic patients. Bone and Mineral. 17. 182–182. 1 indexed citations
6.
Brabant, Georg, Matthias J. Müller, Martin Rotsch, et al.. (1986). Treatment of Carcinoid Syndrome and VIPoma with a Long-Acting Somatostatin Analogue (SMS 201-995). Scandinavian Journal of Gastroenterology. 21(sup119). 177–180. 15 indexed citations
7.
Hesch, R.-D., et al.. (1986). Renal adenylate cyclase assay for biologically active parathyroid hormone: clinical utility and physiological significance. Journal of Endocrinology. 108(1). 9–15. 2 indexed citations
8.
Hesch, R.-D., et al.. (1985). (1-38) Human parathyroid hormone for coherence therapy of osteoporosis. European Journal of Endocrinology. 110(1_Suppla). S171–S172. 5 indexed citations
9.
Hesch, R.-D., et al.. (1985). Parathyroid Hormone and PTHmRNA in a Human Small Cell Lung Cancer. Recent results in cancer research. 99. 88–93. 13 indexed citations
10.
Jüppner, Harald, et al.. (1983). Discrimination between intact and mid-C-regional PTH using selective radioimmunoassay systems. European Journal of Endocrinology. 102(4). 543–548. 29 indexed citations
11.
Jüppner, Harald & R.-D. Hesch. (1982). Inhibition of renal adenylate cyclase by plasma from uremic patients. Journal of Endocrinological Investigation. 5(5). 303–309. 2 indexed citations
12.
Atkinson, Michael J., Harald Jüppner, Robert F. Butz, et al.. (1981). Homologous radioimmunoassay for human mid-regional parathyroid hormone. Journal of Endocrinological Investigation. 4(3). 363–363. 16 indexed citations
13.
Hehrmann, R., et al.. (1980). Plasma-Parathormon nach Nierentransplantation. Journal of Molecular Medicine. 58(5). 249–258. 1 indexed citations
14.
Hehrmann, R., et al.. (1980). Human Parathyroid Hormone: Antibody Characterization. Journal of Immunoassay. 1(2). 151–174. 34 indexed citations
15.
Wilke, Russell A., et al.. (1979). REGULATORY HYPERPARATHYROIDISM IN A PIG BREED WITH VITAMIN D DEPENDENCY RICKETS. European Journal of Endocrinology. 92(2). 295–308. 10 indexed citations
16.
Hesch, R.-D.. (1978). Screening für Neugeborenen-Hypothyreose?. DMW - Deutsche Medizinische Wochenschrift. 103(19). 811–815. 1 indexed citations
17.
Chansel, Dominique, J D Sraer, J.L. Morgat, R.-D. Hesch, & Raymond Ardaillou. (1977). Preparation of biologically active tritium‐labelled 1–34 human parathyroid hormone. FEBS Letters. 78(2). 237–243. 4 indexed citations
18.
Hesch, R.-D.. (1974). Pathophysiologie der Trijodthyroninproduktion. DMW - Deutsche Medizinische Wochenschrift. 99(52). 2649–2656. 3 indexed citations
19.
Hesch, R.-D., et al.. (1973). Plasma triiodothyronine at the end of pregnancy, in the cord blood and in the first days of the newborn. European Journal of Pediatrics. 114(4). 301–304. 6 indexed citations
20.
Fuchs, C., et al.. (1972). A SIMPLE AND PRECISE METHOD FOR DETERMINATION OF IONIZED CALCIUM IN SERUM BY AN IONSELECTIVE ELECTRODE. European Journal of Endocrinology. 68(3_Suppl). S63–S63.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026